Fervent Synergies Limited

Consumer Defensive — Food Distribution · BSE

₹14.50+₹0.71 (+5.15%)

DalalBaazaar Score

67 / 100

🟢 Good

Verdict

NEUTRAL

Risk

High

Driven by moderate debt load, negative free cash flow, micro-cap size, which brings thin liquidity.

In simple words: The business is earning a fairly low return on the money invested in it, though profits are falling even as sales grow. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:07 pm

Caution warranted. Multiple fundamental metrics — flagged in red below — point to either valuation stretch, leverage risk, or weakening profitability. This doesn't mean avoid the stock outright, but it does mean the burden of proof is on the growth story to justify the current price.

Understanding the Business

Company site ↗

The 60-second version of Fervent Synergies Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Fervent Synergies Limited operates in food business in India. It operates through two segments, Foods Division and Finance Division. The company trades in importing and selling almonds. It also engages in funds lending; and investing in fixed term deposits and similar securities.

IndustryFood Distribution

SectorConsumer Defensive

Employees11

Annual revenue₹16 Cr

How does it make money?

Turns over ₹16 Cr a year. Of every ₹100 of sales, about ₹23 reaches shareholders as profit, with ₹24 left at the operating level before interest, tax and depreciation. Each of its 11 employees supports ₹1.49 Cr of revenue a year, the signature of a capital- or asset-led business.

EBITDA margin23.8%

Net margin23.4%

Revenue / employee₹1.49 Cr

Who are its competitors?

The closest listed comparisons in its industry are HINDUSTAN UNILEVER LTD., ITC LTD, NESTLE INDIA LIMITED, BRITANNIA INDUSTRIES LTD. These are the companies its valuation and returns are measured against elsewhere in this report.

HINDUSTAN UNILEVER LTD.P/E 42.5x · ROE 21.5%

ITC LTDP/E 16.6x · ROE 27.4%

NESTLE INDIA LIMITEDP/E 59.8x · ROE 79.9%

BRITANNIA INDUSTRIES LTDP/E 44.1x · ROE 51.0%

What is its competitive advantage?Little sign of one

Returns on capital of 6.6% are at or below what the capital likely costs. That is the financial pattern of a business competing largely on price, where advantage has to come from execution rather than position.

ROCE6.6%

ROE6.7%

Peer median ROE51.0%

What has been driving growth?

Sales and margins have both contributed to where profit is now. Over 3 years revenue moved +253% while net margin moved +370% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+253%

Margin effect+370%

DalalBaazaar Score

67/ 100

Good

Weighted across six categories. Every point is explained below.

✓ Beta of 0.10 — historically steadier than the index
✗ Micro Cap: thinner liquidity and sharper drawdowns are normal
✗ Profits have swung sharply from year to year — earnings are hard to forecast
✗ Negative free cash flow means dependence on external funding

Quality vs. Valuation

Company Quality

68/ 100

Good

How good the business is, ignoring the share price entirely.

Valuation

76/ 100

Cheap

What you are being asked to pay, ignoring how good the business is.

A good business currently available at an undemanding price — the combination this framework is built to look for.

Historical Valuation

Current P/E

19.9x

3Y Median

222.1x

40 monthly readings · mean 164.4x · range 19.1x–347.5x

Sector Median

43.3x

median of 4 sector peers

🟢Current valuation is approximately 91% below its 3y median of 222.1x. Cheaper than its own history, which is worth a reason too: the market may be pricing in something the backward-looking numbers do not show.

🟢Against its sector it trades 54% below the peer median of 43.3x.

vs. its own history

Cheap

222.1x median over 40 months · -91%

vs. sector peers

Cheap

43.3x median of 4 peers · -54%

vs. generic bands

Fair

15x–35x

P/E (Trailing)

19.9x

P/B

1.30x

EV/EBITDA

18.7x

PEG

0.13

Dividend Yield

None

What's Good / What's Bad

🟢 What's Going Well4

Margins are improving
EBITDA margin is up from 10.3% to 23.8% over 3 years.
Return on equity is rising
ROE has improved from 0.5% to 6.7%.
Return on capital is rising
ROCE has improved from 1.0% to 6.6%.
Valuation below its historical average
At 19.9x the stock trades 91% below its own median of 222.1x.

🔴 What Needs Attention1

Free cash flow is negative
The business is not currently covering its capital spending from operations.

Red Flags

2 items require attention · 1 high · 1 watch

🔴Free cash flow negative for 4 yearsFinancial
The business has not covered its capital spending from operations for several years running, which has to be funded externally.
🟡Shareholders have been dilutedOwnership
Shares outstanding are up 67% over 3 years — each existing share owns a smaller slice of the company.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Margin expansion has further to run
EBITDA margin has risen from 10.3% to 23.8%. If that holds, profit compounds faster than sales and today's multiple looks cheaper in hindsight than it does now.
Priced below its own history
The stock trades 91% below its own median multiple. If the business performs as it has and simply re-rates back to normal, that gap is return on its own.
Cheaper than its peers
It trades 54% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.

🔴 Bear CaseWhat could go wrong?

Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 39% a year✓ 52.3% CAGR
Latest reported year was 7.7%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above 22%✓ 23.8%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Free cash flow remains positive✗ -₹4 Cr
Profit that never becomes cash eventually stops being profit.
4Debt / EBITDA stays below 2x✓ 0.2x
The ratio lenders write covenants against; it survives a small or negative equity base, unlike Debt/Equity.
5ROCE stays above 8%✗ 6.6%
Falling returns on capital are usually competition arriving, and show up here before they reach the margin.

Investment Checklist

5 / 11 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✗ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✗ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✗ Short-term technical trend isn't bearish

Price history

Quick Metrics

2 good · 5 neutral · 4 weak

Market Cap

₹73 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

19.9x

Fair

Fairly valued against the generic band

P/B Ratio

1.30x

Reasonable

Reasonable against the company's book value

EPS (TTM)

₹0.73

Profitable

Profitable on a per-share basis

ROE

6.7%

Weak

Weak capital efficiency

ROCE

6.6%

Weak

Low return on total capital employed

Debt/Equity

1.21x

Moderate

Moderate leverage

Revenue Growth (YoY)

7.7%

Modest

Modest growth

Profit Growth (YoY)

-50.0%

Falling

Profits are shrinking

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

-₹4 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

CMP

₹14.5

Operating Margin

27.9%

Good

Healthy core-business profitability

Net Margin

22.1%

Good

Strong bottom-line conversion

Current Ratio

221.55

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.10

Defensive

Steadier than the market

52W Range Position

11%

Near low

Near its 52-week low

Technical Snapshot

SMA 20 / SMA 50

14.7 / 15.0

Bearish alignment (short < long)

Price vs SMA 200

Below

Long-term downtrend

RSI (14)

42.7

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹5 Cr	₹24 Cr	₹32 Cr	₹16 Cr	+52.3%
EBITDA	₹0 Cr	₹2 Cr	₹3 Cr	₹4 Cr	+101.2%
EBITDA Margin	10.3%	6.4%	9.2%	23.8%	—
PAT (Net Profit)	₹0 Cr	-₹13 Cr	₹3 Cr	₹4 Cr	+155.0%
EPS	₹0.08	₹-4.48	₹0.59	₹0.76	+111.8%
ROE	0.5%	-42.3%	6.1%	6.7%	—
ROCE	1.0%	-42.0%	6.0%	6.6%	—
Free Cash Flow	-₹0 Cr	-₹0 Cr	-₹15 Cr	-₹4 Cr	—

🟢 Revenue has grown at 52.3% a year over 3 years.

🟢 EBITDA has grown at 101.2% a year over 3 years.

🟢 EBITDA Margin has risen from 10.3% to 23.8% over 3 years (+13.5 pts).

🟢 PAT (Net Profit) has grown at 155.0% a year over 3 years.

🟢 EPS has grown at 111.8% a year over 3 years.

🟢 ROE has risen from 0.5% to 6.7% over 3 years (+6.2 pts).

🟢 ROCE has risen from 1.0% to 6.6% over 3 years (+5.6 pts).

Balance Sheet & Cash Flow — FY2026

Total Assets

₹58 Cr

Total Liabilities

₹1 Cr

Total Debt

₹1 Cr

Cash & Equivalents

₹0 Cr

Operating Cash Flow

-₹3 Cr

Capex

-₹1 Cr

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

90.4%

Peer Comparison

Company	P/E	ROE
HINDUSTAN UNILEVER LTD.	42.5x	21.5%
ITC LTD	16.6x	27.4%
NESTLE INDIA LIMITED	59.8x	79.9%
BRITANNIA INDUSTRIES LTD	44.1x	51.0%

Recent News

2 mixed4 general

Compare with Fervent Synergies

Equitymaster, 15 Oct

Fervent Synergies Ltd. Peer Comparison – Compare with Others

Value Research, 03 Sept

Fervent Synergies Ltd. Shareholding Pattern – Promoters, FIIs & DIIs

Value Research, 30 Aug

Spandana Sphoorty Financial reports consolidated net profit of Rs 11.88 crore in the June 2026 quarter

Business Standard, 24 JulResults

🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.

Fervent Synergies Ltd. Financials – Balance Sheet, Profit & Loss, Cash Flow

Value Research, 01 Sept

Q1 results 2026: Infosys to IndiGo among companies to declare Q1 results today; full list here

Livemint, 23 JulResults

🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.

Watch Items

Cross-check against the company's latest quarterly filing / investor presentation before acting.

DalalBaazaar Thesis

🟢Business QualityStrong14.3/20

🟡Financial HealthAdequate11.9/20

🟢GrowthStrong14.9/20

🟢ProfitabilityStrong10/15

🟢ValuationAttractive12/15

🔴RiskHigh4/10

Attractive on both counts

A good business currently available at an undemanding price — the combination this framework exists to look for. The work left is qualitative: whether the advantage the numbers imply is one you can identify and expect to last. 1 high-severity red flag sits above this conclusion and should be read first.

This thesis breaks if

✓Revenue growth stays above 39% a year52.3% CAGR
✓EBITDA margin holds above 22%23.8%
✗Free cash flow remains positive-₹4 Cr
✓Debt / EBITDA stays below 2x0.2x
✗ROCE stays above 8%6.6%